Clinical and Molecular Study of Endometriosis and Adenomyosis
Recruiting now
Conditions studied: Endometriosis, Adenomyosis
In brief
The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.
Key facts
- Study ID
- NCT04481321
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 5300
- Starts
- 2006-05-01
- Expected to finish
- 2040-12-01
- Last updated by the study team
- 2025-11-20
Who can join
Age: 18 and older, up to 42. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women of age between - 18 and 42 years old.
- In-service care for one of the pelvic pain and/or infertility, or for a pelvic mass.
- Having a radiological diagnosis made by a referral practitioner and/or operated in the department
You may not qualify if…
- HIV-positive women, HBV and HCV
- During pregnancy
- Having a cancer diagnosis
- Refusing to sign a consent.
Where it is running
- Port Royal, hospital cochin — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.